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Predicting attitude towards performance enhancing substance use: A comprehensive 1 
test of the Sport Drug Control Model with elite Australian athletes 2 
 3 
Abstract 4 
Objective: This study presents a comprehensive examination of the Sport Drug Control 5 
Model via survey data of elite Australian athletes.  6 
Design and method: A cross-sectional nationwide mail survey of 1,237 elite Australian 7 
athletes was conducted. Structural equation modeling was employed to test the model.  8 
Results: Morality (personal moral stance on performance-enhancing substances use), 9 
reference group opinion (perceived moral stance of reference group on performance-10 
enhancing substances use) and legitimacy (perceptions of the drug testing and appeals 11 
processes) evidenced significant relationships with attitude towards performance-enhancing 12 
substances use, which in turn was positively associated with doping behaviour. The model 13 
accounted for 81% and 13% of the variance in attitude towards performance-enhancing 14 
substances use and doping behaviour, respectively.  15 
Conclusion: These findings validate the usefulness of the Sport Drug Control Model for 16 
understanding influences on performance-enhancing substances use. Nevertheless, there is 17 
a need to survey athletes representing a broader range of competition levels and cross-18 
cultural research to test the model‟s applicability to other populations of athletes.    19 
 20 
 21 
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There is limited application and empirical validation of doping models in sport. The lack of 29 
empirical evidence to support or refute these conceptual models leaves a significant gap in 30 
the literature in understanding influences on performance-enhancing substances (PES) use. 31 
 32 
Donovan et al.‟s1 Sport Drug Control Model (SDCM) was the first comprehensive published 33 
theoretical model of factors influencing PES use. The model consists of six components 34 
believed to predict an athlete‟s attitudes and intentions towards PES use: (1) threat 35 
appraisal; (2) benefit appraisal; (3) personal morality; (4) reference group opinion; (5) 36 
legitimacy; and (6) personality. In addition, two „market‟ factors believed to facilitate or inhibit 37 
the translation of attitudes and intentions into behaviour, the affordability and availability of 38 
PES, were included in the model (see Figure 1). Donovan2 later placed the model in two 39 
broader contexts: an overall sociocultural context (e.g., a ready acceptance of new 40 
technologies that save time and effort, prolong life, prevent suffering and enhance body 41 
image and cognitive functioning); and a sport culture that has become medicalised and 42 
commercialised. Similar to Donovan‟s2 expansion, Stewart and Smith‟s3 model of drug use in 43 
sport combines the micro orientation of individual athlete intentions with a macro orientation 44 
on sporting context and culture. The authors argue that decisions made by athletes are not 45 
always rational or bound by clear intentionality. Hence contextual factors may affect athletes‟ 46 
values, beliefs, and decision making. 47 
 48 
Strelan and Boeckmann‟s4 Drugs in Sport Deterrence model postulates that the costs 49 
associated with PES use are weighed up against the benefits of using such substances, and 50 
this cost-benefit analysis is influenced by situational factors. There are no published data 51 
examining the utility of this model. However, Strelan and Boeckmann5 applied the principles 52 
of deterrence theory to hypothetical decisions to use a PES among a sample of 116 53 




Petróczi and Aidman‟s6 life-cycle model of performance enhancement posits that in the 56 
course of their career, athletes constantly set goals and make choices regarding the way 57 
these goals can be achieved. Opportunities for behaviour change, including PES use, are 58 
presented throughout the cycle of choice – goal commitment – execution – feedback on goal 59 
attainment – goal evaluation/adjustment. The model is based on expectancy theory, hence 60 
athletes‟ motivation to engage in PES use is assumed to be influenced by the desire to attain 61 
expected positive outcomes, and, at the same time, controlled by the expected undesirable 62 
outcomes from use of PES. There is no published empirical testing of this model, the 63 
difficulty of which is recognised by the authors: “Considering the complexity and reiterative 64 
nature of the model, empirical testing of the model as a whole is not feasible” (p. 7).6  65 
 66 
Mazanov and Huybers‟7 qualitative research provided support for the variables in these four 67 
models that are purported to influence PES use. Based on their findings, the authors 68 
presented a model of PES use in which 10 factors („choice‟ determinants) thought to 69 
influence an athlete‟s decision to use or abstain from PES use were grouped into four 70 
themes: (1) objective of PES use (expected performance and financial outcomes); (2) about 71 
the PES (sources of information and influence on decision to use PES; expected effects of 72 
PES use on health; (3) the deterrence system (likelihood of detection of PES use; likelihood 73 
of prosecution if caught using PES); and (4) consequences if prosecuted (expected financial 74 
and non-financial consequences). Further, three individual differences variables (termed 75 
„control‟ variables) were included in the model: (1) decision-making style; (2) stage of career; 76 
and (3) type of sport.  77 
 78 
Gucciardi, Jalleh and Donovan8 presented findings from an opportunistic examination of 79 
some of the constructs in the SDCM. Data were from a survey of 643 elite Australian athletes 80 
conducted for the purpose of personality profiling of elite athletes and their susceptibility to 81 
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PES use. Items in the questionnaire were identified that related to the following concepts in 82 
the model: threat appraisal (i.e., perceived likelihood of detection out-of-competition and 83 
while competing; successfully appealing a positive drug test); personality (i.e., self-esteem); 84 
legitimacy (i.e., perceived seriousness and effectiveness of the Australian Sports Anti-Doping 85 
Authority in preventing PES use; perceived security of the drug testing procedures in 86 
Australia); morality (i.e., cheating behaviour); benefit appraisal (i.e., perceived necessity for 87 
athletes to use PES to perform at the very highest levels); and reference group opinion (i.e., 88 
relevant others‟ perceptions of them if they were caught using PES).  89 
 90 
Structural equation modeling (SEM) revealed that the model accounted for 30% of the 91 
variance in attitude towards PES use. Morality, benefit appraisal and threat appraisal 92 
evidenced the strongest relationships with attitude towards PES use. Self-esteem, 93 
perceptions of legitimacy and reference group opinion showed small non-significant 94 
associations with attitude towards PES use. Despite the fact that the questionnaire items 95 
were not constructed to specifically measure the constructs, these findings provided 96 
preliminary support for the model and its usefulness in understanding influences on athletes‟ 97 
attitude towards PES use. This paper presents the findings from a study that purposefully 98 
comprehensively examined the SDCM. 99 
 100 
METHODS 101 
The study design was a cross-sectional nationwide mail survey of elite Australian athletes 102 
conducted in 2004. Curtin University‟s human ethics committee granted approval for this 103 
project. The five Australian Sport Institutes/Sport Academies, the Australian Sports Drug 104 
Agency (now the Australian Sports Anti-Doping Authority), and four national sporting 105 
organisations (Basketball Australia, Australian Football League, National Rugby League, 106 
Australian Rugby Union) were approached to distribute the survey to athletes on their 107 
databases. Only two Australian Sport Institutes/Academies declined to participate in the 108 
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study. Athletes were mailed a package containing the questionnaire, a Curtin University 109 
covering letter, a covering letter from their sporting organisation encouraging athletes to 110 
participate, and a Curtin University-addressed reply-paid envelope. Table 1 presents the 111 
questionnaire items that represented all of the constructs of the SDCM shown in Figure 1. 112 
The major dependent variables were doping behaviour (single item) and attitude towards 113 
PES use (two items). These are listed first in Table 1.  114 
 115 
Of the 1,257 surveys returned (response rate: 26%), 1.6% were excluded due to non-116 
responses to all of the items measuring the dependent variable (i.e., self-reported use of 117 
banned PES). In total, 1,237 cases were used in the analyses.  118 
 119 
Following a basic descriptive and internal reliability analysis using SPSS, AMOS was 120 
employed to assess the model using SEM. Model fit was examined using chi-square 121 
statistics and several other indices for goodness-of-fit: root-mean-square residual (RMR); 122 
root-mean-square error of approximation (RMSEA) and 90% confidence intervals; goodness-123 
of-fit index (GFI); adjusted goodness-of-fit index (AGFI); comparative fit index (CFI); Tucker-124 
Lewis index (TLI); and incremental fit index (IFI).9 For CFI, TLI, IFI, GFI and AGFI values of 125 
0.90 and 0.95 reflect acceptable and excellent fit to the data respectively. For the RMSEA 126 
and RMR, values of 0.05 or less indicate a good fit, and between 0.05 and 0.08 a moderate 127 
fit.9,10    128 
 129 
For each of the single indicator constructs in the structural equation model (i.e., personality, 130 
reference group opinion, availability and affordability of PES), Munck‟s11 formula was used to 131 
calculate both the regression coefficients and measurement error variances. These values 132 
were used for the single indicator constructs in the structural equation model. 133 
 134 
RESULTS  135 
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The sample included both male (n = 603) and female athletes (n = 612) (not specified: n = 136 
22), with a mean age of 23 years (SD = 7.8 years). Athletes were represented from a large 137 
number of sports, including athletics (8.4%), swimming (7.8%), hockey (7.0%), rowing 138 
(6.3%), soccer (5.7%), basketball (4.7%), netball (4.1%), cycling (3.5%), softball (3.3%), AFL 139 
(3.3%), and weight lifting/power lifting (3.1%). Of the total sample, 10.8% had participated in 140 
the Olympics/Paralympics, 46.3% at World Championship events, 37.1% at the national level 141 
and 5.0% at the state/regional level. The vast majority had competed in their sport for five or 142 
more years/seasons (84%) and 60% had attained an international (38%) or national title 143 
(22%).   144 
 145 
Of the total sample, 6.9% reported ever using a banned substance (used in the last 12 146 
months: 3.4%). Among those who had ever been drug tested (n = 759), 1.1% reported 147 
testing positive for a banned PES.  148 
 149 
Descriptive statistics and reliability estimates for the study variables are presented in Table 1. 150 
All of the composite variables (i.e., affordability and availability of PES; benefit appraisal: 151 
improving performance; threat appraisal: threat to health; personal morality: moral emotions; 152 
reference group; personality) showed adequate reliability with alpha coefficient values above 153 
the recommended minimum level of .70.12 Convergent validity was assessed by examining 154 
composite reliability (CR) and average variance extracted (AVE) from the composite 155 
variables. The CR values of the composite variables were between 0.84 and 0.94 and all are 156 
above the suggested minimum of 0.70.12 Their AVE values were all above 0.5, providing 157 
further evidence of convergent validity.13 Evaluation of normality indicated the presence of 158 
multivariate non-normality (Mardia‟s index=58.76). Therefore, assessment of the structural 159 




The results of the SEM analysis are summarised in Figure 2. With the exception of a 162 
significant Bollen–Stine 
2
, which tends to become inflated with a large sample size, fit 163 
indices supported an acceptable fitting model [
2
(162)=653.6, p < .001, Bollen–Stine p = 164 
.001, RMR=.03, GFI=.95, AGFI=.93, CFI=.88, IFI =.88, TLI=.86, RMSEA=.050 (90% CI=.046 165 
to .054)] that accounted for 81% and 13% of the variance in attitude towards PES use and 166 
doping behaviour, respectively.  167 
 168 
Examination of modification indices suggested that affordability be allowed to covary with 169 
availability. Given that affordability and availability of other substances use are commonly 170 
interrelated in terms of consumption,14-15 and were theorised by Donovan et al.1 to be 171 
interrelated in terms of PES use, the model was re-analysed with that change. The refitted 172 
model provided a good fit to the data. A significant Bollen-Stine index of fit was observed 173 
(
2
(161)=564.0, p < .001). All other indices of fit were satisfactory [RMR=.03, GFI=.96, 174 
AGFI=.94, CFI=.90, IFI =.90, TLI=.89, RMSEA=.045 (90% CI=.041 to .049)]. 175 
 176 
The standardised parameter estimates indicate a significant and strong relationship between 177 
attitude towards PES use and personal morality (0.64), a significant and moderate 178 
relationship with legitimacy (0.25), and a significant but lesser relationship with reference 179 
group opinion (0.19). The moderate relationship between attitude towards PES use and 180 
benefit appraisal (0.40) approached significance (p = .091). In turn, PES use was significantly 181 
and moderately associated with attitude towards PES use (0.36). All other relationships were 182 
non-significant (p > .05). 183 
 184 
DISCUSSION 185 
In this study, 1.1% of athletes who were drug tested reported testing positive for a banned 186 
PES. This is consistent with the proportion of samples analysed by the International Olympic 187 
Committee and World Anti-Doping Agency accredited anti-doping laboratories that resulted 188 
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in adverse analytical findings and atypical findings from 1993 to 2011 (ranged between 1.3% 189 
and 2.1%)16,17 Self-reported use of banned PES was 6.9%. This is within the range of self-190 
reported use studies in adult athletes between 1980 and 1996 (5% to 15%)18 and similar to  191 
recent surveys of elite athletes.19,20  Hence we can be reasonably confident that our sample 192 
is representative of the population of athletes with respect to doping behaviour.  193 
 194 
A favourable attitude towards PES use was associated with actual use of a banned 195 
substance thus providing support for past research reporting associations between attitude 196 
towards PES and actual use of these substances among US male college athletes21 and 197 
Australian athletes,8 as well as intentions to use these substances among Italian high school 198 
students22,23 and gym users in the Netherlands.24 The hypothesised relationships between 199 
availability and affordability of PES and the use of these substances were non-significant. 200 
However, this result was impacted by a substantial proportion of athletes reporting that they 201 
did not know whether the six presented substances were accessible or affordable: 47.3% to 202 
61.8% and 58.6% to 69.8% for each substance respectively.  203 
 204 
When considering the six hypothesised psychosocial variables together, personal morality 205 
revealed the strongest association with attitude towards PES use. That is, athletes with a 206 
weaker moral stance against PES use had a more favourable attitude towards PES use. 207 
Donovan et al.1 appears to have been the first published paper to highlight personal morality 208 
as an important component for understanding PES use in sport. In this study, personal 209 
morality was conceptualised and measured in terms of moral judgement towards PES use, 210 
and moral emotions experienced if caught using PES. Since the Donovan et al.1 paper, there 211 
have been no published studies on athletes‟ moral judgement towards PES use and only the 212 
Strelan and Boeckmann5 study investigated moral emotions. In that study, guilt anticipated 213 
from use of human growth hormone was the strongest influence on Australian footballers and 214 
soccer players‟ hypothetical decision not to use that substance. The Strelan and 215 
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Boeckmann‟s5 study and this study provide support for the importance of moral emotions in 216 
influencing PES use. 217 
 218 
In a sporting context, morality has been associated with the concept of cheating, with PES 219 
use viewed by athletes as the most serious form of cheating.25 In Donovan, Jalleh and 220 
Gucciardi‟s26 study, acceptance of cheating as measured by the Attitudes to Moral Decision-221 
Making in Youth Sport Questionnaire27 was significant in differentiating athletes according to 222 
low, moderate and high susceptibility to PES use. In Gucciardi, Jalleh and Donovan‟s8 study, 223 
of the constructs examined, morality – measured in terms of cheating – evidenced the 224 
strongest relationship with attitude towards PES use. More recently there has been 225 
considerable interest in the construct of moral disengagement. For example, studies have 226 
found that moral disengagement is: significantly associated with intentions to use PES,22,28 227 
positively associated with antisocial behaviour (e.g., trying to injure opponents and breaking 228 
the rules of the game); and negatively associated with prosocial behaviour (e.g., helping 229 
injured opponents and congratulating opponents for good play).29 These studies provide 230 
further support for the importance of morality in understanding PES use. 231 
 232 
There was a significant relationship between perceived reference group opinion on the 233 
morality of PES use and attitude towards PES use. The direction of the association was the 234 
same as for personal morality, but the strength of the association was less. There are no 235 
published studies on the moral stance of athletes‟ reference groups on PES use.  236 
 237 
There was a significant moderate relationship between legitimacy and attitude towards PES 238 
use. The components of legitimacy tested were in relation to distributive justice (i.e., 239 
perceived fairness of the drug testing process) and procedural justice (i.e., perceived fairness 240 
of the appeals process). The data supported Donovan et al.‟s1 theorising that if athletes 241 
perceive an anti-doping organisation‟s drug enforcement regime to be fair and just, then the 242 
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legitimacy of the anti-doping organisation in conducting drug testing and prosecution is likely 243 
to be enhanced and compliance with anti-doping regulations is more likely. This is a new and 244 
promising dimension in understanding PES use.  245 
 246 
The moderate relationships between attitude towards PES use and both threat and benefit 247 
appraisals did not reach significance. This is contrary to the findings in Gucciardi, Jalleh and 248 
Donovan‟s8 study in which there was a significant moderate relationship between attitude 249 
towards PES use and benefit appraisal, and a significant but small relationship with threat 250 
appraisal. The inconsistencies in findings may well be due to variations in measurement of 251 
these two constructs between the two studies. In this study, threat appraisal was 252 
conceptualised and measured in terms of threats relating to both ill-health effects of PES use 253 
and enforcement, while benefit appraisal was measured in terms of both rewards for 254 
performing well in sport and perceived impact of PES on performance. In Gucciardi, Jalleh 255 
and Donovan‟s8 study, threat and benefit appraisals were measured only in terms of the 256 
latter measure for each construct (i.e., appraisal of threat of enforcement, and perceived 257 
impact of PES on performance). 258 
 259 
In this study, personality was not a significant predictor of attitude towards PES use. This 260 
finding is consistent with Gucciardi, Jalleh and Donovan‟s8 study. It is noteworthy that both 261 
studies were limited to a single measure of personality: risk taking propensity (this study) and 262 
self-esteem (Gucciardi, Jalleh and Donovan‟s7 study). In line with this study, Donovan, Jalleh 263 
and Gucciardi26 found that risk taking propensity (measured by the Risk Propensity Scale30) 264 
did not significantly differentiate athletes with respect to susceptibility to PES use.  265 
 266 
The model accounted for a substantial proportion of the variance in attitude towards PES use 267 
(81%) but only 13% of the variance in use of PES. Kraus‟s31 meta-analysis of 88 attitude-268 
behaviour studies revealed that attitudes significantly and substantially predicted future 269 
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behaviour. However the reported mean correlation of 0.38 can be considered as a low-270 
moderate correlation. These data highlight the complexity of the attitude-behaviour 271 
relationship and predicting behaviour per se. Notwithstanding attitude towards PES use, 272 
there are a multitude of environmental and situational factors that may facilitate or inhibit 273 
PES use.2 These constitute a rich area for further research.  274 
 275 
The data analysis technique employed in this study (i.e., SEM) allows evaluation of the 276 
hypothesised causal pathways. However, this study is limited by its cross-sectional design 277 
which does not allow causal inferences about the direction of the various relationships in the 278 
model. Longitudinal study designs are required to validate these cross-sectional findings and 279 
make assertions about cause and effect relationships. Since the time of data collection for 280 
this study, there have been published scales measuring some of the concepts in the SDCM, 281 
mainly in relation to attitude towards PES use32 and personality.26 Future studies may 282 
consider the use of these scales to provide a more comprehensive measure of these 283 
constructs. However, consideration must be given to the additional length of the survey 284 
instrument as the Performance Enhancement Attitude Scale consists of 17 items and 285 
Donovan, Jalleh and Gucciardi‟s26 study found that a number of personality variables 286 
differentiated athletes with respect to susceptibility to PES use. 287 
 288 
Research studies on moral disengagement in a sporting context have focused mainly on its 289 
impact on antisocial and prosocial behaviours and attitude towards PES use, but none has 290 
investigated its association with PES use. Given that personal morality is a significant factor 291 
in understanding PES use, research examining and applying mechanisms to morally engage 292 
athletes in relation to PES use warrants further investigation. Future studies could survey 293 
athletes representing a broader range of competition levels and involving cross-cultural 294 
research to test the model‟s applicability and the relative importance and relevance of the 295 





Current anti-doping education programs focus on building awareness and knowledge of 299 
banned PESs, reporting and testing requirements, and penalties for non-compliance. Such 300 
programs may include sporting values to assist athletes in resisting inclinations or invitations 301 
to use banned PES.33 However, this „education‟ approach ignores psychosocial variables 302 
increasingly being found to be related to attitude towards PES use. The results of this study 303 
have a number of implications for anti-doping programs, and particularly with respect to two 304 
largely ignored areas: morality and legitimacy. This study‟s findings suggest that in addition 305 
to educational components, anti-doping prevention may benefit from attention to morality and 306 
legitimacy issues that influence attitude towards PES use.  307 
 308 
Practical implications  309 
 This study comprehensively examined the Sport Drug Control Model via survey data of 310 
elite Australian athletes. 311 
 These findings suggest that anti-doping education programs that include only education 312 
and information on banned PES, reporting and testing requirements, and penalties for 313 
non-compliance will have little impact on susceptible athletes‟ propensity to use PES.  314 
 Based on this study‟s findings, anti-doping education programs would be more effective 315 
in influencing attitude towards and actual use of PES by including components 316 
discussing moral decision making behaviour, moral affect resulting from being caught 317 
using PES, the legitimacy base of the anti-doping organisation, the stringency of drug 318 
testing, and the equitable and fair treatment of all athletes in drug testing and appeals 319 
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Figure Legend: 413 
Fig. 1. The Sport Drug Control Model.1 414 
Fig. 2. Overview of results of structural equation model analysis (n = 1,237). Note: *p < .01; 415 
**p < .001; latent variable indicators are not shown for simplicity reasons. 416 
 
 
Table 1: Descriptive statistics and internal reliability estimates for the variables measuring 
the constructs in the Sport Drug Control Model (N = 1,237) 
Variables Range M SD  CR AVE 
Doping behaviour 
 
(0) Self-reported never use of a PES to (1) self-reported 
ever use of a PES 
.08 .27 --- --- --- 
Attitude towards PES use       
Need to use banned PES to perform at the 
very highest level 
(1) Definitely don’t have to use PES at some time to 
(4) definitely have to use PES at some time 
1.52 .94 --- --- --- 
Consideration of an offer to use PES (1) None at all to (4) a lot of consideration 1.68 .93 --- --- --- 
Affordability of PES 
 
(1) Very expensive to buy to (5) very cheap to buy 2.47 .79 .93 .94 .75 
Availability of PES 
  
(1) Probably impossible/very hard to buy to (5) very 
easy to buy 
2.64 .81 .90 .93 .69 
Benefit appraisal       
Impact of PES on performance (1) Definitely would not improve performance to (5) 
definitely would improve performance 
3.23 1.04 .87 .90 .66 
Table(s)
 
Rewards for performing well   (1) Little rewards to (5) a lot of rewards 3.79 .76 --- --- --- 
Threat appraisal       
Appraisal of threat to health:       
Use of PES once or twice (1) A lot of harm to (5) no harm 2.34 1.03 .91 .93 .69 
Regular use of PES (1) A lot of harm to (5) no harm 1.55 .75 .87 .91 .62 
Appraisal of threat of enforcement:       
Deterrence in competition (1) High threat of detection to (3) low threat of detection 1.44 .53 --- --- --- 
Deterrence out of competition (1) High threat of detection to (3) low threat of detection 1.63 .56 --- --- --- 
Personal morality 
Moral judgment on PES use 
(1) PES use is morally wrong under any circumstances 
to (3) PES is morally OK under any circumstances 
1.11 .32 --- --- --- 
Moral emotions (1) Moral emotions experienced to a great extent to (5) 
moral emotions not experienced at all 
1.06 .29 .80 .88 .71 
Reference group moral judgment on PES 
use 
(1) PES use is morally wrong under any circumstances 
to (3) PES use is morally OK under any circumstances 
1.16 .38 .74 .84 .51 
Legitimacy       
Testing process:       
Security of testing procedure (1) Very secure to (4) not at all secure 1.48 .54 --- --- --- 
 
Equitable treatment of athletes (1) Very fair to (4) very unfair 1.68 .66 --- --- --- 
Appeals process:       
Fair hearing for positive test appeal (1) Very satisfied to (4) very dissatisfied 1.88 .60 --- --- --- 
Fair hearing before decision on sanctions (1) Very satisfied to (4) very dissatisfied 1.88 .64 --- --- --- 
Fair hearing in Court of Arbitration (1) Very satisfied to (4) very dissatisfied 1.82 .56 --- --- --- 
Personality       
Risk taking propensity (1) Risk adverse to (5) risk seeking 3.60 .85 .75 .86 .75 










































Supplement Table: Questionnaire items for the variables measuring the constructs in the Sport Drug Control Model 
Variables/Items 
Doping behaviour: 
Which one of the following most applies to you?  
(1) I have never considered using a banned PES; (2) At one stage I thought briefly about using a banned PES; (3) At one stage I thought 
quite a bit about using a banned PES; (4) I still think occasionally about using a banned PES because other athletes are using them; (5) I 
briefly used a banned PES in the past but no longer do so; (6) I occasionally use a banned PES now for specific purposes; (7) I regularly 
try or use banned PES. 
 
In the last 12 months, have you used any of the following, for whatever reason: anabolic steroids; beta-blockers; human growth hormones 
(hGH); diuretics; doping methods; alphabodies; designer steroids like tetrahydrogestrinone (THG); erythropoietin (EPO) and other similar 
substances? 
(1) Have never used; (2) Did not use in the last 12 months; (3) 1 to 2 times; (4) 3 to 5 times; (5) 6 to 10 times; (6) More than 10 times. 
 
Have you ever tested positive for a banned PES? 
(1) Yes; (2) No. 
Supplementary Material
 
Attitude towards PES use: 
In your sport, how necessary do you believe it is for athletes to use banned PES at least at some time, to perform at the very highest 
levels? 
(1) Definitely have to use banned PES at some time; (2) Probably have to use banned PES at some time; (3) Might or might not have to 
use banned PES at some time; (4) Probably don’t have to use banned PES at some time; (5) Definitely don’t have to use banned PES at 
some time. 
 
If you were offered a banned PES under medical supervision at low or no financial cost and the banned PES could make a significant 
difference to your performance and was currently not detectable, how much consideration do you think you might give to the above offer? 
(1) A lot of  consideration; (2) Some consideration; (3) A little consideration; (4) None at all. 
Affordability of PES: 
How cheap or expensive would it be for you personally to buy each of the following types of substances: anabolic steroids; beta-blockers; 
human growth hormones (hGH); diuretics; designer steroids like tetrahydrogestrinone (THG); erythropoietin (EPO) and other similar 
substances? 
(1) Very cheap; (2) Quite cheap; (3) Neither; (4) Quite expensive; (5) Very expensive; (6) Don’t know. 
Availability of PES: 
How easy or difficult would it be to get each of the following types of substances: anabolic steroids; beta-blockers; human growth 
 
hormones (hGH); diuretics; designer steroids like tetrahydrogestrinone (THG); erythropoietin (EPO) and other similar substances? 
(1) Probably impossible; (2) Very hard; (3) Fairly hard; (4) Fairly easy; (5) Very easy; (6) Don’t know.  
Benefit appraisal: 
If you were to use the following, how likely is it that would improve your performance in your sport: anabolic steroids; beta-blockers; human 
growth hormones (hGH); designer steroids like tetrahydrogestrinone (THG); erythropoietin (EPO) and other similar substances? 
(1) Definitely would not; (2) Probably would not; (3) Might or might not; (4) Probably would; (5) Definitely would; (6) Don’t know.  
 
What outcomes does your sport offer you if you perform well: national celebrity status; lucrative sponsorship deals; personal best 
achievements; opportunities for remaining in the sport as coach, trainer or administrator; future financial security; international celebrity 
status? 
(1) A lot; (2) A little; (3) Not at all. 
 
How much would you like these outcomes for performing well in your sport: national celebrity status; lucrative sponsorship deals; personal 
best achievements; opportunities for remaining in the sport as coach, trainer or administrator; future financial security; international 
celebrity status? 
(1) A lot; (2) A little; (3) Not at all. 
Threat appraisal 
 
Appraisal of threat to health: 
How much harm to your health, if any, do you think would be caused by using each of the following substances once or twice ever: 
anabolic steroids; beta-blockers; human growth hormones (hGH); diuretics; designer steroids like tetrahydrogestrinone (THG); 
erythropoietin (EPO) and other similar substances? 
(1) No harm; (2) A little harm; (3) Some harm; (4) A lot of harm; (5) Don’t know. 
 
How much harm to your health, if any, do you think would be caused by using each of the following substances regularly: anabolic steroids; 
beta-blockers; human growth hormones (hGH); diuretics; designer steroids like tetrahydrogestrinone (THG); erythropoietin (EPO) and 
other similar substances? 
(1) No harm; (2) A little harm; (3) Some harm; (4) A lot of harm; (5) Don’t know. 
 
Appraisal of threat of enforcement: 
How likely is it that athletes at your level would be drug tested at least once a year: out of competition; in competition? 
(1) Very likely; (2) Quite likely; (3) A little likely; (4) Not likely; (5) Not at all likely.  
 
From what you know or have heard, if you were to take banned performance enhancing substances (out of competition)/(while competing), 
how likely do you think that you could get away with it if you really tried to? 
 
(1) Very likely; (2) Quite likely; (3) A little likely; (4) Not likely; (5) Not at all likely.  
 
From what you know or have heard, how likely is it for an athlete to successfully appeal a penalty for a positive drug test in your sport? 
(1) Very likely; (2) Quite likely; (3) A little likely; (4) Not likely; (5) Not at all likely.  
Deterrence in competition 
Deterrence out of competition 
Personal morality:  
Regardless of whether you believe performance enhancing substances should be banned or allowed, which of the following statements 
best describes your personal feelings about deliberately using banned performance enhancing substances? 
(1) I believe deliberately using banned PES to improve performance is morally wrong under any circumstances; (2) I believe deliberately 
using banned PES to improve performance is morally OK under some circumstances, but wrong under others; (3) I believe deliberately 
using banned PES to improve performance is morally OK under any circumstances. 
 
If you were caught using banned performance enhancing substances, to what extent would you experience the following feelings: 
ashamed; embarrassed; guilty? 
(1) Not at all to (5) To a great extent. 
Reference group:  
 
People involved in sports in general: 
What about the following people’s feelings about using banned PES: most other athletes, most spectators, most of the general public, 
sports lawyers in general, sports journalists in general? 
(1) Deliberately using banned PES to improve performance is morally wrong under any circumstances; (2) Deliberately using banned PES 
to improve performance is morally OK under some circumstances, but wrong under others; (3) Deliberately using banned PES to improve 
performance is morally OK under any circumstances. 
Legitimacy: 
Testing process: 
Security of testing procedure: 
How secure is the Australian Sports Drug Agency’s drug testing procedures in Australia? (That is, in taking of samples and care of 
samples). 
(1) Very secure; (2) Quite secure; (3) Not really secure; (4) Not at all secure. 
 
Equitable treatment of athletes: 
How fair is the Australian Sports Drug Agency in terms of treating all athletes equally? 




How satisfied are you that athletes who appeal a positive test in Australia will be given a fair hearing? 
(1) Very satisfied; (2) Somewhat satisfied; (3) Somewhat dissatisfied; (4) Very dissatisfied. 
 
How satisfied are you that athletes who test positive in your sport will be given a fair hearing before a decision is made about applying a 
penalty? 
(1) Very satisfied; (2) Somewhat satisfied; (3) Somewhat dissatisfied; (4) Very dissatisfied. 
 
How satisfied are you that athletes who appeal a positive test before the Court of Arbitration in Sport, will be given a fair hearing? 
(1) Very satisfied; (2) Somewhat satisfied; (3) Somewhat dissatisfied; (4) Very dissatisfied. 
Personality: 
Please indicate whether you agree or disagree, or have mixed feelings with it: I am the kind of person who avoids risk; I am the kind of person who 
enjoys risk? 
(1) Strongly agree; (2) Agree; (3) No feelings/mixed feelings; (4) Disagree; (5) Strongly disagree. 
 
